Marker Therapeutics, Inc. SEC filings MRKR

Marker Therapeutics, Inc. has 904 filings in SEC EDGAR's recent list, going back to Sep 3, 1999. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
10-Q Quarterly report Aug 10, 2021 Jun 30, 2021
10-Q Quarterly report May 12, 2021 Mar 31, 2021
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
10-Q Quarterly report Aug 9, 2019 Jun 30, 2019
10-Q Quarterly report May 10, 2019 Mar 31, 2019
10-Q Quarterly report Nov 13, 2018 Sep 30, 2018
10-Q Quarterly report Aug 9, 2018 Jun 30, 2018
10-Q Quarterly report May 15, 2018 Mar 31, 2018
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
10-Q Quarterly report Aug 7, 2017 Jun 30, 2017
10-Q Quarterly report May 5, 2017 Mar 31, 2017
10-Q Quarterly report Nov 4, 2016 Sep 30, 2016
10-Q Quarterly report Aug 15, 2016 Jun 30, 2016
10-Q Quarterly report May 16, 2016 Mar 31, 2016
10-Q/A Amended quarterly report Apr 14, 2016 Sep 30, 2015
10-Q/A Amended quarterly report Apr 14, 2016 Jun 30, 2015
10-Q/A Amended quarterly report Apr 14, 2016 Mar 31, 2015
10-Q Quarterly report Nov 16, 2015 Oct 30, 2015
10-Q Quarterly report Aug 14, 2015 Jun 30, 2015
10-Q Quarterly report May 15, 2015 Mar 31, 2015
10-Q Quarterly report Nov 19, 2014 Sep 30, 2014
10-Q Quarterly report Aug 18, 2014 Jun 30, 2014
10-Q/A Amended quarterly report May 21, 2014 Mar 31, 2014
10-Q Quarterly report May 20, 2014 Mar 31, 2014
10-Q Quarterly report Nov 19, 2013 Sep 30, 2013
10-Q Quarterly report Aug 19, 2013 Jun 30, 2013
10-Q/A Amended quarterly report Aug 19, 2013 Mar 31, 2013
10-Q Quarterly report May 21, 2013 Mar 31, 2013
10-Q Quarterly report Nov 19, 2012 Sep 30, 2012
10-Q/A Amended quarterly report Sep 12, 2012 Jun 30, 2012
10-Q Quarterly report Aug 20, 2012 Jun 30, 2012
10-Q Quarterly report May 21, 2012 Mar 31, 2012
10-Q Quarterly report Nov 21, 2011 Sep 30, 2011
10-Q/A Amended quarterly report Oct 14, 2011 Mar 31, 2010
10-Q/A Amended quarterly report Oct 14, 2011 Jun 30, 2010
10-Q/A Amended quarterly report Oct 14, 2011 Sep 30, 2010
10-Q Quarterly report Aug 22, 2011 Jun 30, 2011
10-Q Quarterly report May 23, 2011 Mar 31, 2011
10-Q Quarterly report Nov 22, 2010 Sep 30, 2010
10-Q Quarterly report Aug 23, 2010 Jun 30, 2010
10-Q Quarterly report May 24, 2010 Mar 31, 2010
10-Q Quarterly report Nov 16, 2009 Sep 30, 2009
10-Q Quarterly report Aug 19, 2009 Jun 30, 2009
10-Q Quarterly report May 15, 2009 Mar 31, 2009
10-Q Quarterly report Nov 19, 2008 Sep 30, 2008
10-Q Quarterly report Aug 19, 2008 Jun 30, 2008
10-Q Quarterly report May 20, 2008 Mar 31, 2008

Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MRKR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Houston, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1094038
Former names
TAPIMMUNE INC. (until Oct 17, 2018); TAPIMMUNE INC (until Jun 29, 2017); GENEMAX CORP (until Jun 28, 2007); EDUVERSE COM (until Jun 17, 2002)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.